Microfluidic contract design and manufacturing
Minifab's experts in microfluidic product development and manufacture will be exhibiting in Düsseldorf at Medica 2019. Medica, is one of the world's largest events in the medical sector. For more than 40 years it has been firmly established on every expert’s calendar.
Microfluidic point-of-care technologies are a major driving force for improving infectious disease diagnosis in both developed and developing countries. The low cost and portable nature of these devices combined with the ability to achieve rapid diagnosis is enabling health care professionals to better treat infectious diseases and save more lives.
As a microfludic contract developer and manufacturer Minifab has, during the past 16 years, designed and delivered hundreds of successful diagnostic devices to service this growing market.
Leverage our assay expertise
Point-of-Care infectious disease diagnostics are typically based on a molecular assay, although cellular and immunological assays still have an important role to play for some diseases. Minifab's in-house bioscience team are experts in assessing and translating all types of bio-assays for commercial use at the microfluidic scale. Having our bioscience team working along side our product development and manufacturing team enables Minifab to achieve superior design-for-manufacture outcomes, yielding more commercially viable end products.
Think Big about Microfluidics
Our exceptional in-house design, science, engineering and manufacturing teams have earned the reputation for being the best in the world at what they do. No matter what stage of development your product is at we're here to help. From early concept right through to high volume ISO 13485 manufacture, the team you'll meet at Medica will be able to provide you with expert guidance from day one.